Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label, Uncontrolled Study to Investigate the Efficacy and Safety of the Transdermal Contraceptive Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene in a 21-day Regimen for 13 Cycles in 1650 Healthy Female Subjects

NCT00910637 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00910637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00910637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label, Uncontrolled Study to Investigate the Efficacy and Safety of the Transdermal Contraceptive Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene in a 21-day Regimen for 13 Cycles in 1650 Healthy Female Subjects
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
May 1, 2009
Completion date
December 13, 2010
Enrollment
1,502 (actual)
Sites
63

Conditions

As the registry lists them; a condition with its own page is linked.

contraception